Physical Positioning Dramatically Improves Brain Transduction after Intrathecal Infusion of AAV9

被引：0
|
作者：
Castle, Michael J. [1 ]
Cheng, Yuhsiang [1 ]
Asokan, Aravind [2 ,3 ]
Tuszynski, Mark H. [1 ]
机构：
[1] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA
[2] Duke Univ, Sch Med, Dept Surg, Durham, NC USA
[3] Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC USA
来源：
MOLECULAR THERAPY | 2019年 / 27卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
187
引用
收藏
页码：97 / 98
页数：2
相关论文
共 50 条
  • [31] Customized blood-brain barrier shuttle peptide to increase AAV9 vector crossing the BBB and augment transduction in the brain
    Zhang, Xintao
    Chai, Zheng
    Dobbins, Amanda Lee
    Itano, Michelle S.
    Askew, Charles
    Miao, Zhe
    Niu, Hongqian
    Samulski, R. Jude
    Li, Chengwen
    BIOMATERIALS, 2022, 281
  • [32] Differential gene transfer to the choroid plexus after intrathecal delivery or in vitro exposure to AAV5, AAV8, and AAV9 viral vectors
    Churchill, C.
    Schuster, D.
    Schnell, S.
    Kitto, K.
    Peterson, C.
    Vulchanova, L.
    Fairbanks, C.
    JOURNAL OF PAIN, 2014, 15 (04): : S44 - S44
  • [33] AAV9: a potential blood-brain barrier buster
    Manfredsson, Fredric P.
    Rising, Aaron C.
    Mandel, Ronald J.
    MOLECULAR THERAPY, 2009, 17 (03) : 403 - 405
  • [34] Natural AAV2 Variants Demonstrate Stronger Neurotropism, Penetrance of the Blood-Brain Barrier, and Differential Transduction of Brain Regions Compared to AAV9
    Liu, Sophia
    Leland, Thomas
    Muhuri, Manish
    Lotun, Anoushka
    Xu, Meiyu
    Xu, Guangchao
    Luo, Li
    Qin, Wanru
    He, Ran
    Su, Qin
    Xie, Jun
    Wei, Yu-Quan
    Tai, Phillip W. L.
    Gao, Guangping
    MOLECULAR THERAPY, 2023, 31 (04) : 592 - 592
  • [35] Immune Response Activation and Neurotoxicity after Intrathecal Infusion of AAV9 Vector Encoding a Non-Self Reporter Protein in the Non-Human Primate
    Samaranch, Lluis
    San Sebastian, Waldy
    Kells, Adrian P.
    Bringas, John
    Pivirotto, Phillip
    Forsayeth, John
    Bankiewicz, Krystof S.
    MOLECULAR THERAPY, 2013, 21 : S227 - S227
  • [36] Retinal Ganglion Cell Gene Transfer Is Achieved Following Intrathecal Administration of AAV9
    Gray, Steven James
    Han, Zongchao
    Bailey, Rachel
    Rozenberg, Alejandra
    Zheng, Min
    Mitra, Rajendra
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [37] Intrathecal delivery of AAV9 vectors to model and rescue a large animal model of SMA
    Duque, S.
    Porensky, P.
    William, D. A.
    Odermatt, P.
    Nlend, R. Nlend
    Bevan, A. K.
    Foust, K.
    Braun, L.
    Schmelzer, L.
    Schumperli, D.
    Kaspar, B. K.
    Burghes, A. H. M.
    NEUROMUSCULAR DISORDERS, 2013, 23 (9-10) : 797 - 797
  • [38] Gene therapy of MLD model mice by intrathecal and intravenous injection of AAV9 vector
    Miyake, Noriko
    Miyake, Koichi
    Shimada, Takashi
    MOLECULAR GENETICS AND METABOLISM, 2014, 111 (02) : S78 - S79
  • [39] The AAV9 Variant Capsid AAV-F Mediates Widespread Transgene Expression in Nonhuman Primate Spinal Cord After Intrathecal Administration
    Beharry, Adam
    Gong, Yi
    Kim, James C.
    Hanlon, Killian S.
    Nammour, Josette
    Hieber, Kate
    Eichler, Florian
    Cheng, Ming
    Stemmer-Rachamimov, Anat
    Stankovic, Konstantina M.
    Welling, Duane Bradley
    Ng, Carrie
    Maguire, Casey A.
    HUMAN GENE THERAPY, 2022, 33 (1-2) : 61 - 75
  • [40] Biodistribution and Comparative Performance of AAV-TT and AAV9 in the Nonhuman Primate Brain
    Lanciego, Jose L.
    Roda, Elvira
    Jolinon, Nelly
    Linden, Michael
    Henckaerts, Els
    Rico, Alberto J.
    MOLECULAR THERAPY, 2022, 30 (04) : 129 - 130
12345